HOOKIPA Pharma Inc. Annual Income Tax Expense (Benefit) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
HOOKIPA Pharma Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2017 to 2023.
  • HOOKIPA Pharma Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
  • HOOKIPA Pharma Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $163K, a 62.4% decline year-over-year.
  • HOOKIPA Pharma Inc. annual Income Tax Expense (Benefit) for 2023 was $368K, a 60% increase from 2022.
  • HOOKIPA Pharma Inc. annual Income Tax Expense (Benefit) for 2022 was $230K, a 22900% increase from 2021.
  • HOOKIPA Pharma Inc. annual Income Tax Expense (Benefit) for 2021 was $1K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $368K +$138K +60% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-22
2022 $230K +$229K +22900% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 $1K +$1K Jan 1, 2021 Dec 31, 2021 10-K 2024-03-22
2020 $0 $0 Jan 1, 2020 Dec 31, 2020 10-K 2023-03-15
2019 $0 -$24K -100% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-24
2018 $24K +$20K +500% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-18
2017 $4K Jan 1, 2017 Dec 31, 2017 10-K 2020-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.